Remove Life Science Remove Marketing Remove Pharma Companies Remove Production
article thumbnail

Top Life Science News and Trends in 2023 at Xtalks

XTalks

In 2023, there were significant advancements and notable trends in the life sciences. Xtalks compiled a list of its top life science news and trends of 2023, which provided readers with the latest developments, information and expert insights across life science industries, including pharma, biotech and medical device.

article thumbnail

4 Life Sciences Trends for 2023

XTalks

The life sciences and healthcare are among the biggest industries globally, and their significance was particularly highlighted during the past couple of years by the COVID-19 pandemic. Given the hyperfocus on the life sciences thanks to COVID, consumers appear to be more autonomous and vocal about their medical demands and choices.

Insiders

Sign Up for our Newsletter

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

article thumbnail

ODAIA wins $25m funding to boost commercial insights platform for pharma

Pharmaceutical Technology

ODAIA, a life sciences predictive analytics and commercial insights provider, has secured an investment of $25m in its Series B funding round. This software-as-a-service (SaaS) platform is also used by life science brands to launch their drugs, therapeutics and vaccines in the markets, using data-driven solution.

article thumbnail

The benefits of being a family-run pharma company

pharmaphorum

Family businesses across industries including the life sciences sector contribute significantly to the global economy – they represent about half of the world gross domestic product and global employment. The post The benefits of being a family-run pharma company appeared first on.

article thumbnail

HEOR and Market Access Strategies in Today’s Drug Development Landscape – Insights from AstraZeneca’s Dr. Heather McDonald

XTalks

Health economics and outcomes research (HEOR) and market access strategies play a critical role in ensuring that newly approved therapies are made available to patients. Professionals in these roles are facing new challenges when it comes to negotiating coverage for many of the new, innovative treatments that are coming to market.

Marketing 105
article thumbnail

The largest pharma company in Europe calls for interoperability

pharmaphorum

With only 2% to 3% of the current level of available data leveraged, there is substantial room for growth, and Youssef says pharma could help make a significant impact. Ehab graduated from Harvard Business school’s Executive General Management Programme in 2009 and holds a bachelor’s degree in Pharmaceutical Sciences.

article thumbnail

3 ways pharma marketers can draw inspiration from digitally-native brands

pharmaphorum

As pharmaceutical marketers prepare their brands for the future, there are a number of important ways they can learn from digitally-native brands. This is reinforced by web-focused marketing strategies that give them a highly-targeted approach when it comes to marketing execution.”. Be more agile .

Branding 130